SPG(SH:600529) Zheng Quan Zhi Xing·2025-08-25 16:52Meeting Overview - The second meeting of the 11th Board of Directors of Shandong Pharmaceutical Glass Co., Ltd. was held on August 23, 2025, with 9 directors invited, 7 present, and 2 participating via communication [1][2] Financial Reports - The board approved the 2025 semi-annual report and its summary, confirming that the report accurately reflects the company's financial status and operational performance without any false statements or omissions [2][3] - The voting results for the semi-annual report were unanimous with 9 votes in favor [2] Fund Management - A special report on the storage and use of raised funds for the first half of 2025 was also approved, with the same unanimous voting results [2][3] Profit Distribution - The board approved the mid-term profit distribution plan for 2025, which is within the authorization granted by the 2024 annual general meeting [3][4] - The plan allows for distribution based on the company's net profit for the corresponding period [3] Governance Changes - The board approved the renaming of the "Board Strategy Committee" to "Board Strategy and Sustainable Development (ESG) Committee," enhancing governance and decision-making capabilities [4][5] - The board also approved the proposal to abolish the supervisory board, transferring its powers to the audit committee, which requires approval at the upcoming extraordinary general meeting [4][5] Articles of Association - A comprehensive revision of the company's articles of association was approved, with authorization for management to handle related administrative changes [5][6] - The board also approved the formulation and revision of certain governance systems, which will be submitted for approval at the extraordinary general meeting [5][6] Extraordinary General Meeting - The board approved the notice for the 2025 first extraordinary general meeting, with unanimous support [6]